P8A
vs
FTSE Straits Times Singapore

Over the past 5 years, P8A has underperformed FTSE Straits Times Singapore, delivering a return of -64% compared to the FTSE Straits Times Singapore's 1% growth.

Stocks Performance
P8A vs FTSE Straits Times Singapore

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Performance Gap
P8A vs FTSE Straits Times Singapore

Performance Comparison
P8A vs FTSE Straits Times Singapore

1 Month 3 Months 6 Months 1 Year 5 Years 10 Years 20 Years
P8A
Cordlife Group Ltd
2%
-12%
10%
-52%
-64%
-79%
-53%
FTSE Straits Times Singapore
Market Index
N/A
N/A
N/A
N/A
1%
-2%
24%

Cordlife Group Ltd
Glance View

Market Cap
38.4m SGD
Industry
Health Care

Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.

P8A Intrinsic Value
0.26 SGD
Undervaluation 43%
Intrinsic Value
Price

See Also

Back to Top